Profil
Graeme Roy Kaufman served as the Chief Financial Officer of CSL Ltd. from 1984 to 1999.
He was also an Executive Director of Opthea Ltd. from 2002 to 2007.
Kaufman held several non-executive chairman and director positions in various firms such as Bionomics Ltd., Paradigm Biopharmaceuticals Ltd., Anagenics Ltd., and Idt Australia Ltd. He was also an Executive Vice President-Finance at Mesoblast Ltd. Kaufman obtained his undergraduate degree and MBA from the University of Melbourne.
Anciens postes connus de Graeme Kaufman
| Sociétés | Poste | Fin |
|---|---|---|
| PARADIGM BIOPHARMACEUTICALS LIMITED | Président | 24/06/2020 |
| IDT AUSTRALIA LIMITED | Président | 21/11/2017 |
Bionomics Ltd.
Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Président | 08/11/2016 |
| ANAGENICS LIMITED | Directeur/Membre du Conseil | 30/06/2015 |
| MESOBLAST LIMITED | Corporate Officer/Principal | 01/01/2013 |
Formation de Graeme Kaufman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
CSL Innovation Pty Ltd.
CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
CSL Ltd.
CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Anagenics Ltd.
Anagenics Ltd. Household/Personal CareConsumer Non-Durables Develops, manufactures and distributes hair care, therapeutic, prognostic and diagnostic products | Consumer Non-Durables |
Idt Australia Ltd.
Idt Australia Ltd. Pharmaceuticals: MajorHealth Technology Produces, develops and supplies pharmaceutical products | Health Technology |
Opthea Ltd.
Opthea Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for treatment retinal diseases | Health Technology |
Bionomics Ltd.
Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Health Technology |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mesoblast Ltd.
Mesoblast Ltd. BiotechnologyHealth Technology Engages in the development and commercialization of biological and adult stem cells products | Health Technology |
Paradigm Biopharmaceuticals Ltd.
Paradigm Biopharmaceuticals Ltd. Pharmaceuticals: GenericHealth Technology Engages in repurposing the drug, pentosan polysulphate sodium for the treatment of bone marrow edema | Health Technology |
















